Results 91 to 100 of about 5,791,370 (216)

Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England. [PDF]

open access: yes, 2021
Invasive meningococcal disease incidence in England declined from 1.93/100,000 persons (1,016 cases) in 2010-11 to 0.95/100,000 (530 cases) in 2018-19 and 0.74/100,000 in 2019-20 (419 cases). During national lockdown for the coronavirus disease pandemic (
Borrow, R   +15 more
core   +1 more source

Additional file 3 of Risk of sequelae after invasive meningococcal disease

open access: yes, 2022
Additional file 3.
Sidsel Skou Voss (12080137)   +2 more
core   +1 more source

Engineering Bacteria for Medicine: Delivery, Diagnosis, and Therapy

open access: yesiMetaMed, Volume 2, Issue 3, September 2026.
ABSTRACT With rapid advances in synthetic biology and genetic engineering, genetically engineered bacteria (GEB) have emerged as a promising platform for biological therapy, addressing key limitations of conventional drug delivery systems and demonstrating significant clinical potential.
Shiyu Xia   +11 more
wiley   +1 more source

Meningocoxemic Septic Shock; A Case Report and Review of the Literature

open access: yesJournal of Pediatric Emergency and Intensive Care Medicine, 2021
Meningococcal infections that have high mortality and morbidity in childhood and progress rapidly are an important health problem. It is one of the most important emergent diseases of the infectious diseases. Neisseria meningitidis has 13 serogroups.
Murat Özkale   +2 more
doaj   +1 more source

Greater Cochlear Damage in Otogenic Versus Meningogenic Meningitis: Hearing Rehabilitation Implications

open access: yesThe Laryngoscope, Volume 136, Issue 9, Page 3998-4005, September 2026.
Otogenic route of meningitis was associated with greater cochlear hair cell loss in comparison with the meningogenic one in this otopathology study. Neuronal depletion has been traditionally implicated in failed hearing rehabilitation of post‐meningitis deafness.
Matheus Pedrosa Tavares   +5 more
wiley   +1 more source

Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease [PDF]

open access: yesEpidemiology and Infection, 2016
SUMMARYThe Global Meningococcal Initiative (GMI) is an international group of scientists and clinicians with recognized expertise in meningococcal disease including microbiology, immunology, epidemiology, public health and vaccinology. The GMI was established to promote the global prevention of meningococcal disease through education, research and ...
Vazquez, J. A.   +4 more
openaire   +4 more sources

How Do Climatic Factors Directly Influence the Incidence and Risk of Meningococcal Meningitis Across the African Meningitis Belt? A Narrative Literature Review

open access: yesGeoHealth, Volume 10, Issue 9, September 2026.
Abstract Globally, the highest incidence of meningococcal meningitis occurs within the African meningitis belt, spanning 26 countries across sub‐Saharan Africa. Meningococcal meningitis incidence is highly seasonal in this region specifically, with outbreaks mostly occurring during the dry season, characterized by low rainfall and atmospheric humidity,
Molly Cliff   +6 more
wiley   +1 more source

Epidemiology of invasive meningococcal disease in France in 2003

open access: yesEurosurveillance, 2005
National surveillance of invasive meningococcal disease (IMD) is based on mandatory reporting. The case definition for surveillance notification was changed in mid-2002 to include cases without microbiological confirmation. The IMD alert detection system was enhanced in 2003 with daily reporting and weekly analysis by district, serogroup, and age ...
A, Perrocheau, M K, Taha, D, Lévy-Bruhl
openaire   +3 more sources

Summary of ecologic modelling studies evaluating the association between influenza and invasive meningococcal disease (IMD).

open access: yes, 2015
IMD = Invasive meningococcal disease.Summary of ecologic modelling studies evaluating the association between influenza and invasive meningococcal disease (IMD).
Stefano Tempia (298304)   +6 more
core   +1 more source

Engineered Bacterial Membranes as Next‐Generation Platforms for Cancer Immunotherapy

open access: yesSmall Science, Volume 6, Issue 8, August 2026.
Engineered bacterial membrane platforms, including outer membrane vesicles, bacterial ghosts, genetically engineered membranes, and hybrid bacterial–tumor membranes, integrate tumor antigen presentation with intrinsic immune stimulation. These platforms promote dendritic‐cell activation, T‐cell priming, pyroptosis, and synergistic responses with ...
Hafiza Aasia Malik   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy